As the diagnostic landscape evolves, several patterns are emerging across both clinical research and market innovation.

The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...